• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠疫耶尔森氏菌的植物源重组F1、V和F1-V融合抗原可激活先天性和适应性免疫系统的人体细胞。

Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system.

作者信息

Del Prete G, Santi L, Andrianaivoarimanana V, Amedei A, Domarle O, D' Elios M M, Arntzen C J, Rahalison L, Mason H S

机构信息

Department of Internal Medicine, University of Florence and Department of Biomedicine, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.

出版信息

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):133-43. doi: 10.1177/039463200902200115.

DOI:10.1177/039463200902200115
PMID:19309560
Abstract

Plague is still endemic in different regions of the world. Current vaccines raise concern for their side effects and limited protection, highlighting the need for an efficacious and rapidly producible vaccine. F1 and V antigens of Yersinia pestis, and F1-V fusion protein produced in Nicotiana benthamiana administered to guinea pigs resulted in immunity and protection against an aerosol challenge of virulent Y. pestis. We examined the effects of plant-derived F1, V, and F1-V on human cells of the innate immunity. F1, V, and F1-V proteins engaged TLR2 signalling and activated IL-6 and CXCL-8 production by monocytes, without affecting the expression of TNF-alpha, IL-12, IL-10, IL-1beta, and CXCL10. Native F1 antigen and recombinant plant-derived F1 (rF1) and rF1-V all induced similar specific T-cell responses, as shown by their recognition by T-cells from subjects who recovered from Y. pestis infection. Native F1 and rF1 were equally well recognized by serum antibodies of Y. pestis-primed donors, whereas serological reactivity to rF1-V hybrid was lower, and that to rV was virtually absent. In conclusion, plant-derived F1, V, and F1-V antigens are weakly reactogenic for human monocytes and elicit cell-mediated and humoral responses similar to those raised by Y. pestis infection.

摘要

鼠疫在世界不同地区仍然流行。目前的疫苗因其副作用和保护作用有限而令人担忧,这凸显了对一种有效且能快速生产的疫苗的需求。将烟草中产生的鼠疫耶尔森菌的F1和V抗原以及F1-V融合蛋白接种给豚鼠,可使其产生免疫力并抵御强毒性鼠疫耶尔森菌的气溶胶攻击。我们研究了植物源F1、V和F1-V对先天免疫的人类细胞的影响。F1、V和F1-V蛋白参与Toll样受体2(TLR2)信号传导,并激活单核细胞产生白细胞介素-6(IL-6)和CXC趋化因子配体8(CXCL-8),而不影响肿瘤坏死因子-α(TNF-α)、白细胞介素-12(IL-12)、白细胞介素-10(IL-10)、白细胞介素-1β(IL-1β)和CXC趋化因子配体10(CXCL10)的表达。天然F1抗原以及重组植物源F1(rF1)和rF1-V均诱导了相似的特异性T细胞反应,从鼠疫耶尔森菌感染中康复的受试者的T细胞对它们的识别即表明了这一点。鼠疫耶尔森菌致敏供体的血清抗体对天然F1和rF1的识别程度相同,而对rF1-V杂交体的血清学反应性较低,对rV几乎没有反应。总之,植物源F1、V和F1-V抗原对人类单核细胞的反应原性较弱,并引发与鼠疫耶尔森菌感染所引发的相似的细胞介导和体液反应。

相似文献

1
Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system.鼠疫耶尔森氏菌的植物源重组F1、V和F1-V融合抗原可激活先天性和适应性免疫系统的人体细胞。
Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):133-43. doi: 10.1177/039463200902200115.
2
A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.一种单组分二价LcrV-F1疫苗可保护非人类灵长类动物免受肺鼠疫感染。
Vaccine. 2009 May 26;27(25-26):3471-4. doi: 10.1016/j.vaccine.2009.01.050. Epub 2009 Feb 5.
3
A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.用表达耶尔森氏鼠疫杆菌分泌型F1和V抗原的减毒鼠伤寒沙门氏菌经鼻内和/或联合口服免疫小鼠后,对实验性鼠疫的免疫原性和保护性免疫的比较。
FEMS Immunol Med Microbiol. 2007 Oct;51(1):58-69. doi: 10.1111/j.1574-695X.2007.00280.x. Epub 2007 Jul 19.
4
Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine.用鼠疫F1-V疫苗的干粉制剂和替代给药方式在小鼠中实现的保护性免疫。
Clin Vaccine Immunol. 2009 May;16(5):719-25. doi: 10.1128/CVI.00447-08. Epub 2009 Mar 4.
5
Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.使用烟草花叶病毒平台进行鼻内递送蛋白质亚基疫苗可预防肺鼠疫。
Vaccine. 2016 Nov 11;34(47):5768-5776. doi: 10.1016/j.vaccine.2016.09.063. Epub 2016 Oct 13.
6
Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.通过口服表达叶绿体中F1-V抗原的植物细胞实现有效的鼠疫疫苗接种。
Infect Immun. 2008 Aug;76(8):3640-50. doi: 10.1128/IAI.00050-08. Epub 2008 May 27.
7
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.F1/V融合蛋白在减毒鼠伤寒沙门氏菌中的表达及对小鼠的鼠疫保护作用。
Microb Pathog. 1997 Sep;23(3):167-79. doi: 10.1006/mpat.1997.0141.
8
A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.一种共表达鼠疫耶尔森菌F1-V融合蛋白的鼻腔白细胞介素-12 DNA疫苗可提供针对肺鼠疫的保护。
Infect Immun. 2008 Oct;76(10):4564-73. doi: 10.1128/IAI.00581-08. Epub 2008 Aug 11.
9
Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.鞭毛蛋白-F1-V融合蛋白是一种对小鼠和两种非人灵长类动物有效的鼠疫疫苗。
Clin Vaccine Immunol. 2009 Jan;16(1):21-8. doi: 10.1128/CVI.00333-08. Epub 2008 Nov 5.
10
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.重组(F1+V)疫苗可保护食蟹猴免受肺鼠疫。
Vaccine. 2011 Jun 24;29(29-30):4771-7. doi: 10.1016/j.vaccine.2011.04.084. Epub 2011 May 12.

引用本文的文献

1
Recent Progress on Vaccines Produced in Transgenic Plants.转基因植物生产疫苗的最新进展
Vaccines (Basel). 2022 Nov 3;10(11):1861. doi: 10.3390/vaccines10111861.
2
Plague Prevention and Therapy: Perspectives on Current and Future Strategies.鼠疫的预防与治疗:当前及未来策略展望
Biomedicines. 2021 Oct 9;9(10):1421. doi: 10.3390/biomedicines9101421.
3
The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts.下一代抗菌肽作为治疗具有社会和经济影响疾病的分子治疗工具。
Drug Discov Today. 2017 Feb;22(2):234-248. doi: 10.1016/j.drudis.2016.10.017. Epub 2016 Nov 23.
4
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.植物源重组乙肝疫苗的十年进展
Int J Mol Sci. 2016 Oct 13;17(10):1715. doi: 10.3390/ijms17101715.
5
Plague Vaccines: Status and Future.鼠疫疫苗:现状与未来
Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12.
6
Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.植物生产的新兴和再现传染病及生物恐怖制剂候选对策。
Plant Biotechnol J. 2015 Oct;13(8):1136-59. doi: 10.1111/pbi.12475.
7
Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.HIV-1 包膜残基 649-684 膜近端区域肽与鼠疫抗原 F1-V 融合的体液免疫原性。
Vaccine. 2011 Aug 5;29(34):5584-90. doi: 10.1016/j.vaccine.2011.06.007. Epub 2011 Jul 13.
8
Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.叶绿体衍生疫苗抗原通过口服或注射给药可同时预防霍乱和疟疾。
Plant Biotechnol J. 2010 Feb;8(2):223-42. doi: 10.1111/j.1467-7652.2009.00479.x. Epub 2009 Dec 28.
9
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.烟草是生产治疗性蛋白的高效绿色生物反应器。
Biotechnol Adv. 2010 Mar-Apr;28(2):214-21. doi: 10.1016/j.biotechadv.2009.11.008. Epub 2009 Dec 2.